remoxipride has been researched along with Basal Ganglia Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 8 (72.73) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klieser, E; Lemmer, W; Strauss, WH | 1 |
| Eriksson, L | 1 |
| Lundström, J; Nilsson, LB; Ogren, SO | 1 |
| Amman, J; Beckmann, H; Bunse, J; Eikmeier, G; Geretsegger, C; Hebenstreit, GF; Kanitz, RD; Kanzow, WT; Laux, G; Schubert, H | 1 |
| Gerlach, J | 1 |
| Cosyns, P; de Bleeker, E; Deleu, G; Lotstra, F; Masson, A; Mendlewicz, J; Mertens, C; Parent, M; Peuskens, J; Suy, E | 1 |
| Bartels, M; Bauer, H; Bunse, J; Gallhofer, B; Haas, S; Kanzow, WT; Klieser, E; Küfferle, B; Pflug, B; Stein, D | 1 |
| Englund, A; Lawrie, V; Lewander, T; Morrison, D; Schlachet, A; Westerbergh, SE | 1 |
| Chouinard, G; Kallai-Sanfacon, MA; Turnier, L | 1 |
| Andersson, U; Häggström, JE; Nilsson, MI; Widerlöv, E | 1 |
| Gerlach, J; Lund Laursen, A | 1 |
1 review(s) available for remoxipride and Basal Ganglia Diseases
| Article | Year |
|---|---|
New antipsychotics: classification, efficacy, and adverse effects.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Receptors, Glutamate; Receptors, Neurotransmitter; Receptors, Serotonin; Remoxipride; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride | 1991 |
8 trial(s) available for remoxipride and Basal Ganglia Diseases
| Article | Year |
|---|---|
The tolerability and efficacy of the atypical neuroleptic remoxipride compared with clozapine and haloperidol in acute schizophrenia.
Topics: Adult; Basal Ganglia Diseases; Clozapine; Cognition; Double-Blind Method; Drug Tolerance; Emotions; Female; Haloperidol; Humans; Male; Neurologic Examination; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1994 |
A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Delayed-Action Preparations; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia | 1991 |
New antipsychotics: classification, efficacy, and adverse effects.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Receptors, Glutamate; Receptors, Neurotransmitter; Receptors, Serotonin; Remoxipride; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride | 1991 |
A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Psychotic Disorders; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
A double-blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
Safety evaluation in both short- and long-term treatment of schizophrenia with remoxipride.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Overdose; Female; Haloperidol; Hemodynamics; Humans; Long-Term Care; Male; Prolactin; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Blood Chemical Analysis; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Electrocardiography; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Remoxipride | 1988 |
Antipsychotic effect of remoxipride, a new substituted benzamide with selective antidopaminergic activity.
Topics: Adult; Basal Ganglia Diseases; Benzamides; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Prolactin; Remoxipride; Schizophrenia | 1986 |
3 other study(ies) available for remoxipride and Basal Ganglia Diseases
| Article | Year |
|---|---|
Remoxipride in the treatment of psychoses.
Topics: Adult; Basal Ganglia Diseases; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, Dopamine D2; Remoxipride; Retrospective Studies; Schizophrenia | 1994 |
Concentrations of remoxipride and its phenolic metabolites in rat brain and plasma. Relationship to extrapyramidal side effects and atypical antipsychotic profile.
Topics: Animals; Basal Ganglia Diseases; Brain; Catalepsy; Chromatography, High Pressure Liquid; Circadian Rhythm; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Male; Rats; Rats, Sprague-Dawley; Remoxipride; Salicylamides; Spectrophotometry, Ultraviolet | 1993 |
Remoxipride in schizophrenia: effects on plasma prolactin.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Female; Humans; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia | 1985 |